BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 33978330)

  • 1. Biological markers and follow-up after discharge home of patients with COVID-19 pneumonia.
    Gutiérrez Gabriel S; Domínguez García MJ; Pérez Mañas G; Moreno García N; Silvan Domínguez M; Andrés EM
    Emergencias; 2021 Jun; 33(3):174-180. PubMed ID: 33978330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implications of neutrophil-lymphocyte ratio in COVID-19.
    Jimeno S; Ventura PS; Castellano JM; García-Adasme SI; Miranda M; Touza P; Lllana I; López-Escobar A
    Eur J Clin Invest; 2021 Jan; 51(1):e13404. PubMed ID: 32918295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.
    Wang Z; Wang Z
    BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia.
    Li J; He X; Yuan Yuan ; Zhang W; Li X; Zhang Y; Li S; Guan C; Gao Z; Dong G
    Am J Infect Control; 2021 Jan; 49(1):82-89. PubMed ID: 32540370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
    Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
    Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal changes of haematological and radiological findings of the COVID-19 infection-a review of literature.
    Lim AYH; Goh JL; Chua MCW; Heng BH; Abisheganaden JA; George PP
    BMC Pulm Med; 2021 Jan; 21(1):37. PubMed ID: 33482780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Patients Who Return to Hospital Following Discharge from Hospitalization for COVID-19.
    Somani SS; Richter F; Fuster V; De Freitas JK; Naik N; Sigel K; ; Bottinger EP; Levin MA; Fayad Z; Just AC; Charney AW; Zhao S; Glicksberg BS; Lala A; Nadkarni GN
    J Gen Intern Med; 2020 Oct; 35(10):2838-2844. PubMed ID: 32815060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting mortality in geriatric patients hospitalized with COVID-19.
    Bağ Soytaş R; Ünal D; Arman P; Suzan V; Emiroğlu Gedik T; Can G; Korkmazer B; Karaali R; Börekçi Ş; Kuşkucu MA; Yavuzer H; Suna Erdinçler D; Döventaş A
    Turk J Med Sci; 2021 Apr; 51(2):454-463. PubMed ID: 33315348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality and Readmission Rates Among Patients With COVID-19 After Discharge From Acute Care Setting With Supplemental Oxygen.
    Banerjee J; Canamar CP; Voyageur C; Tangpraphaphorn S; Lemus A; Coffey C; Wald-Dickler N; Holtom P; Shoenberger J; Bowdish M; Yee HF; Spellberg B
    JAMA Netw Open; 2021 Apr; 4(4):e213990. PubMed ID: 33792728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine laboratory testing to determine if a patient has COVID-19.
    Stegeman I; Ochodo EA; Guleid F; Holtman GA; Yang B; Davenport C; Deeks JJ; Dinnes J; Dittrich S; Emperador D; Hooft L; Spijker R; Takwoingi Y; Van den Bruel A; Wang J; Langendam M; Verbakel JY; Leeflang MM;
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013787. PubMed ID: 33211319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Revisit after discharge from the emergency department in a cohort of patients with COVID-19 pneumonia and analysis based on the healthcare resource used for follow-up. RESALSEVID study].
    Albert A; Llorens P; Aguirre A; Martín-Sánchez FJ; Mínguez S; Moreno O; Ferré C; Valls A; Espinosa B; Murillo O; Cirera I; Gil A; Rivera S; Llopis F; Malchair P; Gonzalez Del Castillo J; Jacob J;
    J Healthc Qual Res; 2023; 38(1):26-34. PubMed ID: 35739038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and management of COVID-19 patients accessing the emergency department in a hospital in Northern Italy in March and April 2020.
    Caramello V; Maciotta A; De Salve AV; Gobbi V; Ruffino TM; Mazzetti G; Ricagni L; Ling C; Arione R; Boccuzzi A; Costa G; Sacerdote C; Ricceri F
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):208-215. PubMed ID: 33412812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocytes screening on admission is essential for predicting in-hospital clinical outcome in COVID-19 patients: A retrospective cohort study.
    Nie L; Liu Y; Weng Y; Zheng Y; Cai L; Kou G; Xiong Z; Liu L
    Int J Lab Hematol; 2021 Dec; 43(6):1302-1308. PubMed ID: 34192413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Recombinant Human Granulocyte Colony-Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia: A Randomized Clinical Trial.
    Cheng LL; Guan WJ; Duan CY; Zhang NF; Lei CL; Hu Y; Chen AL; Li SY; Zhuo C; Deng XL; Cheng FJ; Gao Y; Zhang JH; Xie JX; Peng H; Li YX; Wu XX; Liu W; Peng H; Wang J; Xiao GM; Chen PY; Wang CY; Yang ZF; Zhao JC; Zhong NS
    JAMA Intern Med; 2021 Jan; 181(1):71-78. PubMed ID: 32910179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 and the impact of arterial hypertension-An analysis of the international HOPE COVID-19 Registry (Italy-Spain-Germany).
    El-Battrawy I; Nuñez-Gil IJ; Abumayyaleh M; Estrada V; Manuel Becerra-Muñoz V; Uribarri A; Fernández-Rozas I; Feltes G; Arroyo-Espliguero R; Trabattoni D; López-País J; Pepe M; Romero R; Castro-Mejía AF; Cerrato E; Capel Astrua T; D'Ascenzo F; Fabregat-Andres O; Signes-Costa J; Marín F; Buonsenso D; Bardají A; Jesús Tellez M; Fernández-Ortiz A; Macaya C; Akin I
    Eur J Clin Invest; 2021 Nov; 51(11):e13582. PubMed ID: 34409593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.
    Bosaeed M; Mahmoud E; Hussein M; Alharbi A; Alsaedy A; Alothman A; Aljeraisy M; Alqahtani H; Nashabat M; Almutairi B; Almaghaslah M; Aldibasi O; AlJohani S; Bouchama A; Arabi Y; Alaskar A
    Trials; 2020 Oct; 21(1):904. PubMed ID: 33129363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haematological profile of COVID-19 patients from a centre in Singapore.
    Long VS; Ngiam JN; Chew N; Tham SM; Lim ZY; Li T; Cen S; Annadurai JK; Thant SM; Tambyah PA; Santosa A; Teo WZY; Yap ES; Cross GB; Sia CH
    Hematology; 2021 Dec; 26(1):1007-1012. PubMed ID: 34871520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.